Teva and Active Biotech put laquinimod into Phase III
Pharma Times (subscription) - London,UK
Israel's Teva Pharmaceutical Industries says that it will begin late-stage studies on the novel multiple sclerosis candidate laquinimod, along with its ...
See all stories on this topic

Active Biotech drug could have the edge in oral MS race
BiopharmaReporter.com - Montpellier,France
Developed by Swedish firm Active Biotech and licensed to pharma giant Teva, laquinimod is just one of the competitors in the race to become the first oral ...
See all stories on this topic

Teva, Swedish partner starting Phase III trials of oral drug for MS
Ha'aretz - Tel Aviv,Israel
Teva and Active Biotech are undertaking two global Phase III trials of laquinimod this year, in the United States, Europe, and other locations worldwide. ...
See all stories on this topic

Teva And Active Biotech To Initiate Pivotal Phase III Trial ...
PipelineReview.com (press release) - Barcelona,Spain
Teva Pharmaceutical Industries Ltd. and Active Biotech AB today announced that the companies are initiating a clinical Phase III program for laquinimod, ...
See all stories on this topic

Publication Of Largest Ever Study Of Genetics Of Common Diseases
Medical News Today Sun, 10 Jun 2007 5:04 AM PDT
The Wellcome Trust Case Control Consortium, the largest ever study of the genetics behind common diseases such as diabetes, rheumatoid arthritis and coronary heart disease, has published its results in the journals Nature and Nature Genetics.The ??9 million study is one of the UK's largest and most successful academic collaborations to date. [click link for full article]

Scientists to meet in San Diego to discuss genes
North County Times Sat, 09 Jun 2007 8:05 PM PDT
SAN DIEGO - Scientists will meet in San Diego next week to compare notes on whether some particular human genes may be responsible for more than one type of disease.

Strengthening Exercises May Slow Progression Of ALS
Medical News Today Sun, 10 Jun 2007 0:04 AM PDT
Moderate strengthening exercises may help people with early stage ALS maintain function and quality of life longer, according to a study published in the June 5, 2007, issue of Neurology?, the scientific journal of the American Academy of Neurology. [click link for full article]

After Epilepsy Surgery, Quality Of Life Related More To Seizures Than Memory
Medical News Today Sun, 10 Jun 2007 0:04 AM PDT
Epilepsy surgery can eliminate seizures for 60 to 85 percent of people with temporal lobe epilepsy who do not respond well to medications. But surgery leads to memory problems in 25 to 40 percent of people. New research helps doctors and patients weigh the risks and benefits of surgery. [click link for full article]

Belgrade woman graduates from MMA despite Lyme disease
Capital Weekly Sat, 09 Jun 2007 10:37 PM PDT
BELGRADE LAKES ??? On May 5, Danielle Fotter graduated magna cum laude from Maine Maritime Academy with a bachelor???s degree in interdisciplinary studies, which included business management and small vessel operations.

International Collaboration Uncovers Genetic Commonalities
RedNova Sat, 09 Jun 2007 1:10 PM PDT
SAN DIEGO, June 9 /PRNewswire/ -- The Federation of Clinical Immunology Societies (FOCIS) has taken on the role of connecting multiple disease specific, genetic consortia under the FOCIS Network of Consortia in an effort to uncover the genetic basis of autoimmunity.

Advanced Imaging Technique Allows For More Accurate Neurosurgery
Medical News Today Sat, 09 Jun 2007 0:06 AM PDT
The brain is a very complicated place. From the outside, it may look like a gray lump of tissue, covered with ridges and bumps. But inside, an incredibly complex network of thread-like white fibers carries signals back and forth between areas of the brain and the spinal cord. Each fiber is crucial to a particular aspect of how our mind communicates with our body. [click link for full article]